Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
A 2025-2026 randomized controlled pilot study by Xiangyi Zheng investigating the efficacy and safety of Qingre Huatan Formula (QHF) for preventing early neurological deterioration in acute ischemic stroke patients. The trial involved 72 patients treated within 48 hours of symptom onset, with outcomes tracked up to 90 days. The dataset likely contains patient-level data on NIHSS scores, modified Rankin Scale scores, and treatment assignments.
The primary file format is DOCX, which may require specific tools for parsing structured data.